A review of The EU Cosmetics Regulation: A Conference on Compliance

TSGE Forum hosted the 2013 conference on the EU Cosmetics Regulation providing an overview of the intricacies since its 11 July 2013 implementation

The EU Cosmetic Regulation: A Conference on Compliance was run by TSGE Forum and looked to cut the red tape and clarify various sections of the new Regulation as Chris McLeod reports

The EU Cosmetic Regulation has been put into action since 11th July 2013 turning the previous Directive, as advised by the European Commission (EC), into a legislative Regulation. TSGE Forum brought together five speakers in the Mercure Abbey Hill Hotel in Milton Keynes to provide the audience with clarifications as to what the new Regulation demands. The topics discussed herein will be produced in more detail on cosmeticsbusiness.com in a series of Regulation related articles each month in 2014.

An Overview of the Regulation

David Munden, a consultant for TSGE LLP who has worked in the cosmetics industry since 1963 and is an Honorary Member of The Society of Cosmetic Scientists of where he is also a past President, acted as chairman for the day and provided the first talk. Munden has worked in the cosmetics industry since 1963 and is an Honorary Member of The Society of Cosmetic Scientists of which he is a past President. He stated that the purpose of this conference was not to cover every sector of this regulation but instead to provide concise summaries on the topics that enquires have shown to be of main interest, concern or that have the most ambiguity attached to them.

Munden’s first topic looked to outline the key provisions in the Cosmetic Regulation 1223/2009. He stated that this legislation is a recast and simplification of everything that has been released as a Directive since the first Directive in 1976 and that it provided market harmonisation and greater assurance of consumer safety. On consumer safety, the Regulation states that a cosmetic product made available on the market shall be safe for human health when used under normal or reasonably foreseeable conditions of use, taking into account, in particular: presentation including conformity, labelling, instructions for use and disposal and any other indication or information provided in the Product Information File (PIF).

. . .

This is a small extract of the full article which is available ONLY to premium content subscribers. Subscribers sign-in (top right) to read the article.

Or

Subscribe now to premium content on Cosmetics Business

Companies